July 2022

Office of Clinical Research Making Strides

The Office of Clinical Research is adding functionality and services – from educational opportunities to study feasibility and financial services – that will help take our clinical research enterprise to the next level.

Twitter Users Soured on Flavored e-Cigs Following FDA Ban

Research led by UR CTSI scientists shows how Twitter users’ perceptions toward e-cigarettes changed following two policies from the FDA and New York state that banned flavored e-cigs.

Juilee Thakar Serves as New Translational Biomedical Science PhD Program Director

On July 1, Juilee Thakar, Ph.D., stepped into the role of director for the UR CTSI’s Translational Biomedical Science PhD Program, relieving interim director Edwin van Wijngaarden, Ph.D.